More specifically, we found that the pan-cancer harmful SIGs were significantly enriched with several cancer-relevant hallmarks, such as epithelial mesenchymal transition, DNA repair, glycolysis, hypoxia, apoptosis, MYC target, p53 pathway, and E2F targets (see full significant list in Table S4) [28,29]. The gene discussed is TP53; the disease is cancer.